For families weighing difficult decisions

Family Decision Guide

A practical, evidence-focused guide to help families weigh ibogaine as a potential option for a loved one with substance use disorder.

This guide is for careful research, not a substitute for medical or legal advice. Urgent safety concerns call for urgent, local professional help.

Close-up image accompanying a family guide for researching ibogaine decisions

Start with what is known—and what is not

Families may encounter personal accounts, observational studies, and strong promises. Those are not the same as completed randomized clinical evidence. For ibogaine, the evidence base remains limited, and families should treat claims about outcomes with care.

Ibogaine is a psychoactive alkaloid associated with the iboga plant; its basic pharmacology and history are documented, but that background does not establish a safe or effective treatment plan for any individual.

The setting changes the questions

Where families may encounter ibogaine

Ibogaine may be discussed in ceremonial settings, overseas clinics, underground provider networks, or research contexts. These settings can differ substantially in oversight, emergency readiness, screening practices, and the accuracy of what is communicated to families.

Landscape image accompanying questions families can ask before considering an ibogaine setting

Questions to ask any provider

What screening is required before a person is accepted, and who reviews the information?
How are medications, substance use, cardiac history, and mental health history assessed?
Will an ECG be required and reviewed before any dosing decision?
What emergency equipment, trained personnel, and transfer plan are available on site?
What happens if screening identifies a reason not to proceed?
What follow-up and continuing-care planning is available after the immediate setting ends?

For a wider orientation to the subject, the ibogaine research overview can help families distinguish practical questions from promotional language. It is also useful to understand how this resource approaches its evidence and safety principles before relying on any information source.

Bring records, not assumptions

Prepare for the first serious conversation

A careful discussion begins with documentation that can be checked. Families should not assume that an informal history is enough when a decision may involve substance use, medications, and possible cardiac risk.

A / MEDICAL HISTORY

Gather the full picture

Bring known diagnoses, past hospitalizations, fainting episodes, seizures, allergies, mental health history, and any available records of heart-related concerns.

B / MEDICATIONS

List every substance

Include prescribed medicines, over-the-counter products, supplements, alcohol, and other substances. Do not leave out intermittent or recently stopped use.

C / CARDIAC RECORDS

Ask about ECG results

Bring any existing ECG results and ask how a current ECG would be obtained, interpreted, and used in screening. QT prolongation and arrhythmia concerns are central safety questions.

Safety is not a detail

Know the risks that should stop the conversation

Ibogaine has been associated with QT prolongation, arrhythmia, and death. These risks should not be minimized because a setting is described as natural, traditional, private, or medically supervised. The FDA’s drug safety information explains why serious adverse-event concerns require careful attention, even though jurisdiction-specific regulatory decisions and product status can differ.

Legal and regulatory status also varies by jurisdiction. Families should verify the rules where they live and where any proposed service would occur rather than relying on a provider’s summary. International travel can add practical and legal complexity, including continuity of care on return.

Before any decision

Request answers in writing where possible.
Discuss urgent overdose risk and a practical emergency plan.
Seek independent medical advice using complete, current information.
Check whether the proposed setting’s claims can be verified.

Next steps that do not depend on ibogaine

Keep evidence-based care and overdose-risk reduction in view

Families do not need to settle every question about ibogaine before taking safer next steps. Standard evidence-based care, assessment by qualified local professionals, and practical support can remain important regardless of whether ibogaine is being discussed.

The SAMHSA National Helpline describes a U.S. route to treatment referral information. In an overdose emergency, use local emergency services; in the United States, CDC overdose-prevention guidance also emphasizes the urgency of preventing fatal overdose.

A measured decision is still a decision

Use this guide to make the next conversation more specific.

Keep a written record of questions, documentation, risk concerns, legal checks, and available evidence-based options. The goal is not a quick answer; it is a safer, more informed path for the person you care about.

Explore family research context